Table 3.
Covariate | Univariate analysis | Adjusted/Multivariable analysis | ||||
---|---|---|---|---|---|---|
|
|
|||||
HR | p | 95% CI | AHR | p | 95% CI | |
Youth-focused site | ||||||
No* | 1 | 1 | ||||
Yes | 1.03 | 0.82 | [0.83–1.27] | 1.09 | 0.56 | [0.80–1.50] |
Age at enrolment (years) | ||||||
<20* | 1 | 1 | ||||
≥20 | 1.07 | 0.51 | [0.88–1.31] | 0.94 | 0.62 | [0.72–1.22] |
Became pregnant during the study | 1 | |||||
No* | 1 | |||||
Yes | 0.68 | 0.005 | [0.53–0.89] | 1.10 | 0.63 | [0.75–1.61] |
Males | 0.97 | 0.78 | [0.54–1.24] | 1.08 | 0.63 | [0.80–1.46] |
Marital status at enrolmenta | ||||||
Not married* | 1 | 1 | ||||
Married/partnered | 1.15 | 0.25 | [0.91–1.45] | 0.84 | 0.23 | [0.62–1.12] |
Currently working at enrolment | ||||||
No* | 1 | 1 | ||||
Yes | 1.22 | 0.39 | [0.78–1.89] | 0.99 | 0.99 | [0.59–1.67] |
Baseline CD4 count (cells/mm3)b | ||||||
<250* | 1 | 1 | ||||
250–349 | 0.84 | 0.40 | [0.57–1.25] | 0.63 | 0.071 | [0.39–1.04] |
≥350 | 0.84 | 0.19 | [0.66–1.09] | 0.59 | 0.015 | [0.39–0.90] |
Baseline WHO stagec | ||||||
Stage I/II* | 1 | 1 | ||||
Stage III/IV | 1.04 | 0.77 | [0.81–1.33] | 1.20 | 0.29 | [0.86–1.67] |
Education level at enrolmentd | ||||||
None* | 1 | 1 | ||||
Primary | 0.97 | 0.95 | [0.66–2.61] | 1.44 | 0.47 | [0.53–3.93] |
Secondary | 1.00 | 1.00 | [0.37–2.72] | 1.06 | 0.90 | [0.38–2.95] |
Tertiary | 0.94 | 0.92 | [0.31–2.87] | 0.66 | 0.50 | [0.19–2.22] |
ART status at LTFU | ||||||
Ever started* | 1 | 1 | ||||
Never started | 1.52 | <0.001 | [1.22–1.89] | 4.0 | <0.001 | [2.70–5.88] |
Disclosed HIV infection statuse | ||||||
Yes* | 1 | 1 | ||||
No | 1.22 | 0.074 | [0.98–1.52] | 1.43 | 0.008 | [1.10–1.89] |
Reference category.
Marital status was missing for 158 patients (17%).
CD4 cell count was missing for 132 patients (14%).
WHO staging was missing for 15 patients (2%).
Educational status was missing for 90 patients (10%).
Disclosure status was missing for 65 patients (7%).